{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:27:10Z","timestamp":1791239230444,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>While Alzheimer\u2019s disease (AD) remains one of the most challenging diseases to tackle, genome-wide genetic\/epigenetic studies reveal many disease-associated risk loci, which sheds new light onto disease heritability, provides novel insights to understand its underlying mechanism and potentially offers easily measurable biomarkers for early diagnosis and intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analyzed whole-genome DNA methylation data collected from peripheral blood in a cohort (<jats:italic>n<\/jats:italic>\u2009=\u2009649) from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) and compared the DNA methylation level at baseline among participants diagnosed with AD (<jats:italic>n<\/jats:italic>\u2009=\u200987), mild cognitive impairment (MCI, <jats:italic>n<\/jats:italic>\u2009=\u2009175) and normal controls (<jats:italic>n<\/jats:italic>\u2009=\u2009162), to identify differentially methylated regions (DMRs). We also leveraged up to 4\u00a0years of longitudinal DNA methylation data, sampled at approximately 1\u00a0year intervals to model alterations in methylation levels at DMRs to delineate methylation changes associated with aging and disease progression, by linear mixed-effects (LME) modeling for the unchanged diagnosis groups (AD, MCI and control, respectively) and U-shape testing for those with changed diagnosis (converters).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>When compared with controls, patients with MCI consistently displayed promoter hypomethylation at methylation QTL (mQTL) gene locus PM20D1. This promoter hypomethylation was even more prominent in patients with mild to moderate AD. This is in stark contrast with previously reported hypermethylation in hippocampal and frontal cortex brain tissues in patients with advanced-stage AD at this locus. From longitudinal data, we show that initial promoter hypomethylation of PM20D1 during MCI and early stage AD is reversed to eventual promoter hypermethylation in late stage AD, which helps to complete a fuller picture of methylation dynamics. We also confirm this observation in an independent cohort from the Religious Orders Study and Memory and Aging Project (ROSMAP) Study using DNA methylation and gene expression data from brain tissues as neuropathological staging (Braak score) advances.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results confirm that PM20D1 is an mQTL in AD and demonstrate that it plays a dynamic role at different stages of the disease. Further in-depth study is thus warranted to fully decipher its role in the evolution of AD and potentially explore its utility as a blood-based biomarker for AD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-020-00984-5","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:30:05Z","timestamp":1607517005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer\u2019s disease and implicate its dynamic role in disease progression"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5026-8529","authenticated-orcid":false,"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Readhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel T.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"issue":"3","key":"984_CR1","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"key":"984_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fnbeh.2015.00347","volume":"9","author":"JV Sanchez-Mut","year":"2015","unstructured":"Sanchez-Mut JV, Graff J. Epigenetic alterations in Alzheimer\u2019s disease. Front Behav Neurosci. 2015;9:347.","journal-title":"Front Behav Neurosci"},{"key":"984_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fgene.2018.00579","volume":"9","author":"X Liu","year":"2018","unstructured":"Liu X, Jiao B, Shen L. The epigenetics of Alzheimer\u2019s disease: factors and therapeutic implications. Front Genet. 2018;9:579.","journal-title":"Front Genet"},{"key":"984_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnins.2019.00476","volume":"13","author":"M Esposito","year":"2019","unstructured":"Esposito M, Sherr GL. Epigenetic modifications in alzheimer\u2019s neuropathology and therapeutics. Front Neurosci. 2019;13:476.","journal-title":"Front Neurosci"},{"issue":"4","key":"984_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/erm.10.17","volume":"10","author":"VV Levenson","year":"2010","unstructured":"Levenson VV. DNA methylation as a universal biomarker. Expert Rev Mol Diagn. 2010;10(4):481\u20138.","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"984_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jalz.2017.10.002","volume":"14","author":"PD Fransquet","year":"2018","unstructured":"Fransquet PD, Lacaze P, Saffery R, McNeil J, Woods R, Ryan J. Blood DNA methylation as a potential biomarker of dementia: a systematic review. Alzheimers Dement. 2018;14(1):81\u2013103.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"984_CR7","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/nn.3786","volume":"17","author":"PL De Jager","year":"2014","unstructured":"De Jager PL, Srivastava G, Lunnon K, Burgess J, Schalkwyk LC, Yu L, et al. Alzheimer\u2019s disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci. Nat Neurosci. 2014;17(9):1156\u201363.","journal-title":"Nat Neurosci"},{"issue":"9","key":"984_CR8","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/nn.3782","volume":"17","author":"K Lunnon","year":"2014","unstructured":"Lunnon K, Smith R, Hannon E, De Jager PL, Srivastava G, Volta M, et al. Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer\u2019s disease. Nat Neurosci. 2014;17(9):1164\u201370.","journal-title":"Nat Neurosci"},{"issue":"7388","key":"984_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Graff","year":"2012","unstructured":"Graff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 2012;483(7388):222\u20136.","journal-title":"Nature"},{"issue":"1","key":"984_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13072-018-0211-3","volume":"11","author":"G Gasparoni","year":"2018","unstructured":"Gasparoni G, Bultmann S, Lutsik P, Kraus TFJ, Sordon S, Vlcek J, et al. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer\u2019s disease-specific changes in the human cortex. Epigenetics Chromatin. 2018;11(1):41.","journal-title":"Epigenetics Chromatin"},{"issue":"12","key":"984_CR11","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.jalz.2018.01.017","volume":"14","author":"RG Smith","year":"2018","unstructured":"Smith RG, Hannon E, De Jager PL, Chibnik L, Lott SJ, Condliffe D, et al. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer\u2019s disease neuropathology. Alzheimers Dement. 2018;14(12):1580\u20138.","journal-title":"Alzheimers Dement"},{"key":"984_CR12","doi-asserted-by":"crossref","unstructured":"Altuna M, Urdanoz-Casado A, Sanchez-Ruiz de Gordoa J, Zelaya MV, Labarga A, Lepesant JMJ, et al. DNA methylation signature of human hippocampus in Alzheimer's disease is linked to neurogenesis. Clin Epigenetics. 2019;11(1):91.","DOI":"10.1186\/s13148-019-0672-7"},{"issue":"5","key":"984_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41591-018-0013-y","volume":"24","author":"JV Sanchez-Mut","year":"2018","unstructured":"Sanchez-Mut JV, Heyn H, Silva BA, Dixsaut L, Garcia-Esparcia P, Vidal E, et al. PM20D1 is a quantitative trait locus associated with Alzheimer\u2019s disease. Nat Med. 2018;24(5):598\u2013603.","journal-title":"Nat Med"},{"issue":"1\u20132","key":"984_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000357126","volume":"38","author":"O Kaut","year":"2014","unstructured":"Kaut O, Ramirez A, Pieper H, Schmitt I, Jessen F, Wullner U. DNA methylation of the TNF-alpha promoter region in peripheral blood monocytes and the cortex of human Alzheimer\u2019s disease patients. Dement Geriatr Cogn Disord. 2014;38(1\u20132):10\u20135.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"9","key":"984_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jalz.2016.02.009","volume":"12","author":"L Yu","year":"2016","unstructured":"Yu L, Chibnik LB, Yang J, McCabe C, Xu J, Schneider JA, et al. Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: the relation to Alzheimer\u2019s disease pathology. Alzheimers Dement. 2016;12(9):942\u201351.","journal-title":"Alzheimers Dement"},{"key":"984_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1471-2164-15-145","volume":"15","author":"AK Smith","year":"2014","unstructured":"Smith AK, Kilaru V, Kocak M, Almli LM, Mercer KB, Ressler KJ, et al. Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type. BMC Genomics. 2014;15:145.","journal-title":"BMC Genomics"},{"issue":"11","key":"984_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1080\/15592294.2015.1100786","volume":"10","author":"E Hannon","year":"2015","unstructured":"Hannon E, Lunnon K, Schalkwyk L, Mill J. Interindividual methylomic variation across blood, cortex, and cerebellum: implications for epigenetic studies of neurological and neuropsychiatric phenotypes. Epigenetics. 2015;10(11):1024\u201332.","journal-title":"Epigenetics"},{"issue":"12","key":"984_CR18","doi-asserted-by":"publisher","first-page":"e8274","DOI":"10.1371\/journal.pone.0008274","volume":"4","author":"AE Teschendorff","year":"2009","unstructured":"Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Gayther SA, Apostolidou S, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS ONE. 2009;4(12):e8274.","journal-title":"PLoS ONE"},{"key":"984_CR19","doi-asserted-by":"crossref","unstructured":"Muller-Ehrenberg L, Riphagen JM, Verhey FRJ, Sack AT, Jacobs HIL, Alzheimer's disease neuroimaging I. Alzheimer's disease biomarkers have distinct associations with specific hippocampal subfield volumes. J Alzheimers Dis. 2018;66(2):811\u201323.","DOI":"10.3233\/JAD-180676"},{"issue":"5","key":"984_CR20","doi-asserted-by":"publisher","first-page":"e1000952","DOI":"10.1371\/journal.pgen.1000952","volume":"6","author":"JR Gibbs","year":"2010","unstructured":"Gibbs JR, van der Brug MP, Hernandez DG, Traynor BJ, Nalls MA, Lai SL, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010;6(5):e1000952.","journal-title":"PLoS Genet"},{"key":"984_CR21","doi-asserted-by":"crossref","unstructured":"Holtzman DM, Morris JC, Goate AM. Alzheimer's disease: the challenge of the second century. Sci Transl Med. 2011;3(77):77sr1.","DOI":"10.1126\/scitranslmed.3002369"},{"issue":"1","key":"984_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13148-020-0814-y","volume":"12","author":"JV Sanchez-Mut","year":"2020","unstructured":"Sanchez-Mut JV, Glauser L, Monk D, Graff J. Comprehensive analysis of PM20D1 QTL in Alzheimer\u2019s disease. Clin Epigenetics. 2020;12(1):20.","journal-title":"Clin Epigenetics"},{"issue":"Suppl 2","key":"984_CR23","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.5213\/inj.1938196.098","volume":"23","author":"B Kim","year":"2019","unstructured":"Kim B, Choi Y, Kim HS, Im HI. Methyl-CpG binding protein 2 in Alzheimer dementia. Int Neurourol J. 2019;23(Suppl 2):S72-81.","journal-title":"Int Neurourol J"},{"issue":"1","key":"984_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13059-019-1708-1","volume":"20","author":"CJ Gunasekara","year":"2019","unstructured":"Gunasekara CJ, Scott CA, Laritsky E, Baker MS, MacKay H, Duryea JD, et al. A genomic atlas of systemic interindividual epigenetic variation in humans. Genome Biol. 2019;20(1):105.","journal-title":"Genome Biol"},{"issue":"1","key":"984_CR25","doi-asserted-by":"publisher","first-page":"17605","DOI":"10.1038\/s41598-018-35871-w","volume":"8","author":"AF McRae","year":"2018","unstructured":"McRae AF, Marioni RE, Shah S, Yang J, Powell JE, Harris SE, et al. Identification of 55,000 replicated DNA methylation QTL. Sci Rep. 2018;8(1):17605.","journal-title":"Sci Rep"},{"issue":"46","key":"984_CR26","doi-asserted-by":"publisher","first-page":"23232","DOI":"10.1073\/pnas.1913199116","volume":"116","author":"KK Benson","year":"2019","unstructured":"Benson KK, Hu W, Weller AH, Bennett AH, Chen ER, Khetarpal SA, et al. Natural human genetic variation determines basal and inducible expression of PM20D1, an obesity-associated gene. Proc Natl Acad Sci USA. 2019;116(46):23232\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"key":"984_CR27","doi-asserted-by":"crossref","unstructured":"Yeh TS, Wang JD, Ku LJ. Estimating life expectancy and lifetime healthcare costs for Alzheimer's disease in Taiwan: does the age of disease onset matter? J Alzheimers Dis. 2019.","DOI":"10.3233\/JAD-181060"},{"key":"984_CR28","doi-asserted-by":"crossref","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278(16):1349\u201356.","DOI":"10.1001\/jama.1997.03550160069041"},{"issue":"8","key":"984_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease: the gateway to precision medicine. Nat Rev Neurol. 2018;14(8):457\u201369.","journal-title":"Nat Rev Neurol"},{"key":"984_CR30","doi-asserted-by":"publisher","first-page":"180142","DOI":"10.1038\/sdata.2018.142","volume":"5","author":"PL De Jager","year":"2018","unstructured":"De Jager PL, Ma Y, McCabe C, Xu J, Vardarajan BN, Felsky D, et al. A multi-omic atlas of the human frontal cortex for aging and Alzheimer\u2019s disease research. Sci Data. 2018;5:180142.","journal-title":"Sci Data"},{"issue":"5","key":"984_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-013-1151-4","volume":"126","author":"JB Toledo","year":"2013","unstructured":"Toledo JB, Xie SX, Trojanowski JQ, Shaw LM. Longitudinal change in CSF Tau and Abeta biomarkers for up to 48 months in ADNI. Acta Neuropathol. 2013;126(5):659\u201370.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"984_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med. 2020;26(3):379\u201386.","journal-title":"Nat Med"},{"issue":"5","key":"984_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ, Janelidze S, Benedet AL, Rodriguez JL, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19(5):422\u201333.","journal-title":"Lancet Neurol"},{"issue":"2","key":"984_CR34","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.cell.2016.05.071","volume":"166","author":"JZ Long","year":"2016","unstructured":"Long JZ, Svensson KJ, Bateman LA, Lin H, Kamenecka T, Lokurkar IA, et al. The secreted enzyme PM20D1 regulates lipidated amino acid uncouplers of mitochondria. Cell. 2016;166(2):424\u201335.","journal-title":"Cell"},{"issue":"29","key":"984_CR35","doi-asserted-by":"publisher","first-page":"E6937","DOI":"10.1073\/pnas.1803389115","volume":"115","author":"JZ Long","year":"2018","unstructured":"Long JZ, Roche AM, Berdan CA, Louie SM, Roberts AJ, Svensson KJ, et al. Ablation of PM20D1 reveals N-acyl amino acid control of metabolism and nociception. Proc Natl Acad Sci USA. 2018;115(29):E6937\u201345.","journal-title":"Proc Natl Acad Sci USA"},{"key":"984_CR36","doi-asserted-by":"crossref","unstructured":"Kim JT, Jedrychowski MP, Wei W, Fernandez D, Fischer CR, Banik SM, et al. A plasma protein network regulates PM20D1 and N-acyl amino acid bioactivity. Cell Chem Biol. 2020.","DOI":"10.1016\/j.chembiol.2020.04.009"},{"issue":"9","key":"984_CR37","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tem.2010.05.005","volume":"21","author":"S Merlo","year":"2010","unstructured":"Merlo S, Spampinato S, Canonico PL, Copani A, Sortino MA. Alzheimer\u2019s disease: brain expression of a metabolic disorder? Trends Endocrinol Metab. 2010;21(9):537\u201344.","journal-title":"Trends Endocrinol Metab"},{"issue":"s1","key":"984_CR38","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.3233\/JAD-179911","volume":"64","author":"JR Clarke","year":"2018","unstructured":"Clarke JR, Ribeiro FC, Frozza RL, De Felice FG, Lourenco MV. Metabolic dysfunction in Alzheimer\u2019s disease: from basic neurobiology to clinical approaches. J Alzheimers Dis. 2018;64(s1):S405\u201326.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"984_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nat Rev Neurosci. 2019;20(3):148\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"984_CR40","doi-asserted-by":"crossref","unstructured":"Barthelemy NR, Horie K, Sato C, Bateman RJ. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer's disease. J Exp Med. 2020;217(11).","DOI":"10.1084\/jem.20200861"},{"key":"984_CR41","doi-asserted-by":"crossref","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease versus other neurodegenerative disorders. JAMA. 2020.","DOI":"10.1001\/jama.2020.12134"},{"issue":"14","key":"984_CR42","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"5","key":"984_CR43","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491\u20138.","journal-title":"Nat Genet"},{"key":"984_CR44","doi-asserted-by":"crossref","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinform. 2013;43:11 0 1\u201333.","DOI":"10.1002\/0471250953.bi1110s43"},{"issue":"6","key":"984_CR45","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012;9(6):628\u201345.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"984_CR46","doi-asserted-by":"publisher","first-page":"646","DOI":"10.2174\/156720512801322663","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Buchman AS, Barnes LL, Boyle PA, Wilson RS. Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res. 2012;9(6):646\u201363.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"984_CR47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/bioinformatics\/bty713","volume":"35","author":"TJ Gorrie-Stone","year":"2019","unstructured":"Gorrie-Stone TJ, Smart MC, Saffari A, Malki K, Hannon E, Burrage J, et al. Bigmelon: tools for analysing large DNA methylation datasets. Bioinformatics. 2019;35(6):981\u20136.","journal-title":"Bioinformatics"},{"issue":"24","key":"984_CR48","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"2","key":"984_CR49","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4161\/epi.23470","volume":"8","author":"YA Chen","year":"2013","unstructured":"Chen YA, Lemire M, Choufani S, Butcher DT, Grafodatskaya D, Zanke BW, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray. Epigenetics. 2013;8(2):203\u20139.","journal-title":"Epigenetics"},{"issue":"4","key":"984_CR50","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"984_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff AE, Marabita F, Lechner M, Bartlett T, Tegner J, Gomez-Cabrero D, et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics. 2013;29(2):189\u201396.","journal-title":"Bioinformatics"},{"issue":"1","key":"984_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"key":"984_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 2012;13:86.","journal-title":"BMC Bioinform"},{"issue":"10","key":"984_CR54","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/bioinformatics\/btu049","volume":"30","author":"MJ Aryee","year":"2014","unstructured":"Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014;30(10):1363\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"984_CR55","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/ije\/dyr238","volume":"41","author":"AE Jaffe","year":"2012","unstructured":"Jaffe AE, Murakami P, Lee H, Leek JT, Fallin MD, Feinberg AP, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41(1):200\u20139.","journal-title":"Int J Epidemiol"},{"key":"984_CR56","doi-asserted-by":"crossref","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmertest package: tests in linear mixed effects models. J Stat Softw. 2017;82(13).","DOI":"10.18637\/jss.v082.i13"},{"issue":"4","key":"984_CR57","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1177\/2515245918805755","volume":"1","author":"U Simonsohn","year":"2018","unstructured":"Simonsohn U. Two lines: a valid alternative to the invalid testing of U-shaped relationships with quadratic regressions. Adv Methods Pract Psychol Sci. 2018;1(4):538\u201355.","journal-title":"Adv Methods Pract Psychol Sci"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00984-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13148-020-00984-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00984-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T12:33:07Z","timestamp":1607517187000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00984-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["984"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00984-5","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}